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Abstract
Background: Although the symptomatology of Cuprum metallicum is quite vast, its other salts have fragmentary proving. Thus, homoeopathic
pathogenetic trial for Cuprum aceticum (Cu acet.) was taken up. Objective: To elicit the pathogenetic response to Cu acet. in homoeopathic
potencies on healthy human provers. Materials and Methods: A multi‑center, double‑blind randomized, placebo controlled, trial was conducted
at three centers of Central Council for Research in Homoeopathy. Proving was conducted on 50 relatively healthy provers selected after
conducting the Pretrial Medical Examination. All the provers were given placebo during the first phase of the trial. In the next two phases, Cu acet.
was administered in 6 C and 30 C potencies, in the intervention group (n = 34); and placebo in the placebo group (n = 16), after randomization.
The proving data so generated on Cu acet. were compiled and analyzed at the proving‑cum‑data processing cell. Results: Out of 34 provers
who were on actual drug trial, only 12 provers manifested symptoms. Twenty‑six and 20 symptoms were manifested in 6C and 30C potency,
respectively. Conclusion: The pathogenetic response elicited during the proving trial expands the scope of use of the homoeopathic medicine
C. aceticum. The symptoms generated in this trial will carry more value when verified clinically.
Keywords: Cuprum aceticum, Double blind, Drug proving, Homoeopathy, Pathogenetic effect, Placebo, Verdigris

Introduction
Cuprum aceticum (Cu acet.) is commonly known as acetate
of copper. It is seen that cuprum and its salts are used for
medical properties since ancient times. The book De Materia
Medica by Dioscorides (first century A. D.) describes the use
of verdigris (made by exposing metallic copper to vinegar
steam to form copper acetate) in combination with copper
sulfate as a remedy for bloodshot eyes, inflamed eyes, “fat
in the eyes,” and cataracts.[1] Copper was also employed in
ancient India and Persia to treat lung diseases. The tenth
century book, Liber Fundamentorum Pharmacologiae
describes the use of copper compounds for medicinal
purposes in ancient Persia. Powdered malachite was
sprinkled on boils, copper acetate and copper oxide were
used for diseases of the eye and for the elimination of “yellow
bile.” In 1885, the French physician, Luton, reported on using
copper acetate in his practice to treat arthritis patients. For
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external application, he made a salve of hog’s lard and 30%
neutral copper acetate. For internal treatment, he used pills
containing 10 mg of copper acetate.[2]
Quoting from the Allen’s Encyclopedia of Pure Materia
Medica, “Dr. Samuel Hahnemann, in his Fragmenta, 1805,
gives symptoms under the heading of “Cuprum vitriolatum”
and in 1824 contributed to Franz’s collection in the Archiv.
f. Hom., where “Cu acet.” is directed to be used. Franz’s
collection also includes symptoms by Franz, Fr. H‑n,
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Herrmann, and Ruckert, as well as various poisoning cases
contributed by Dr. Hahnemann.”[3]
Although the symptomatology of Cuprum metallicum is quite
vast in homoeopathic materia medica, its other salts have
fragmentary provings.
Homoeopathic drug proving is not only an integral part, but the
first step to find out the pathogenetic effect of a drug substance.
Hence, this proving was conducted to assess the therapeutic
effect of Cu acet.

Description

Details and chemical properties of cuprum acetate are as
follows:
Copper (II) acetate monohydrate (Cu [II] acetate) is odourless
and efflorescent. It is soluble in alcohol and slightly soluble in
ether and glycerol. Cu (II) acetate has many applications, as
a fungicide, insecticide, catalyst for organic reactions, as well
as applications in electrolysis and electroplating.[4]
Cu (II) acetate is used in the biochemical applications such as
DNA extraction. Cu (II) complexes have been evaluated for
anticancer, antibacterial, and antifungal activities. These are
known to cleave DNA; however, increased efficiency is seen
in the presence of an oxidizer (often hydrogen peroxide).[5]

Materials and Methods
Study design and study setting

A multicenter prospective, randomized, double blind, placebo
controlled study with allocation ratio of verum: placebo
as 70:30 was conducted at three institutes of the Central
Council for Research in Homoeopathy (CCRH): Dr. D. P.
Rastogi Central Research Institute of Homoeopathy, Noida,
Regional Research Institute of Homoeopathy, Gudivada
and Homoeopathic Drug Research Institute, Lucknow.
Proving Master was Research Officer of the Council, having
post graduate degree in Homoeopathy whereas, Honorary
Consultants were the experts of various specialties of modern
medicine engaged in the examination of volunteers/provers.
Medical experts constituted both of them.

Participants
Selection of provers

Applications were invited from 15 to 20 volunteers
(from each center) of both sexes and age 18 years and above
through a notice placed on the notice board of the institutes and
homoeopathic colleges. The volunteers of non-homoeopathic
background were also considered for the study. Pretrial medical
examination (PME) was then conducted for 76 volunteers after
getting written informed consent from them, 05 of which were
from the non-homoeopathic background. Detailed physical,
pathological, and radiological examinations were conducted by
the medical experts to ensure the health status of the volunteers
before enrolment into the study. For the pathogenetic drug trial
of Cu acet, a total of 50 volunteers were enrolled as provers.
78

Inclusion and exclusion criteria

Volunteers of both sexes with age more than 18 years, certified
as healthy by the medical experts, found capable of carefully
recording the facts, subjective, and objective symptoms
generated by the drug during proving and those who had not
taken any homoeopathic medicines in the last 2 months were
included in the study.
Volunteers suffering from any acute or chronic disease,
color blindness, anxiety or hysteria, having any addictions,
undergoing any kind of medical treatment, undergone surgery
in last 2 months, women during pregnancy, puerperium or
lactating, and those who had participated in another clinical
or proving trial during the last 6 months were excluded from
the study.

Sample size

Sample size was determined as per the Drug Proving Protocol
of the Council,[6] according to which there should be at least
15 provers at each center, 30% of whom shall act as control.
Therefore, 50 provers were enrolled at three centers for this
trial. 34 provers were under verum group and 16 were under
placebo group.

Randomization and blinding

Provers were randomized in two groups using stratified
randomization technique for each center, Group I: Homoeopathic
medicine group and Group II: Placebo group. Random numbers
were generated with the help of computer‑based software
available at www.randomizer.org,[7] and the random code
for the provers along with the information about the group
allocation was kept at CCRH headquarters. The decoding of
the group was done after the compilation of the symptoms
produced in both the groups.
Both homoeopathic drug and placebo were dispensed in
identical form, visually indistinguishable from each other, from
Nodal Office of Drug Proving Programme at Dr. D. P. Rastogi
Central Research Institute (Homoeopathy), Noida. Provers,
Proving Master and the Programme Officer were investigators
and kept blinded to the group allocation and also to the identity
of the drug. All the provers were assigned code numbers and
coded drugs of different potencies were supplied in separate
glass phials bearing code numbers of the respective prover.

Intervention
Homoeopathic group

Homoeopathic dilutions of Cu acet. in 6C and 30C potencies
in 100 ml sealed bottles were procured from a Good
Manufacturing Practices certified Homoeopathic Drug
manufacturer, Hahnemann Publishing Company Private Ltd.,
Kolkata, India. Globules of number 30 were medicated with
these dilutions at the proving‑cum‑data processing cell at Nodal
office of Drug Proving.

Placebo group

Placebo consisted of nonmedicated globules (number 30)
moistened with nonmedicated dispensing alcohol (unsuccussed)
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and was therefore indistinguishable from verum in appearance,
taste, and color.

Duration of study

•

Proving period: 1 year (2014–2015).

Ethics and consent

The Council’s 18th Ethical Committee approved the study
protocol on June 19, 2014. Proving Masters with experience
in drug proving were sensitized about the protocol. Written
informed consent was received from all the volunteers prior to
enrolment in the study, after providing the detailed information
about the trial.
All procedures were in accordance with the ethical standards
of the responsible committee on human experimentation and
with the Helsinki Declaration of 1975, as revised in 2013.[8]

Procedure

Study was conducted in three phases at each of the centers. In
each phase, 12 doses of drug or placebo as per randomization
were administered, divided in four doses/day for 3 days (if no
symptom arises).
Phase‑I: Placebo phase. All the provers were given Placebo in
Phase I. It is useful in generating prover’s response to placebo
in both the groups, and therefore, symptoms generated by the
prover in this stage act as control for subsequent phases.
Phase‑II: In the 2nd phase, the verum group received the drug
in 6C potency and Placebo group received optically identical
placebo.
Phase‑III: In the 3rd phase, the verum group received the drug
in 30C potency and Placebo group received optically identical
placebo.
At each study center, a Proving Master supervised the volunteers
enrolled in the study. After receiving the informed consent,
PME, the baseline characteristics equivalent to Homoeopathic
interview and the findings with respect to all the systemic
examination and laboratory investigations (Complete Blood
Count, Blood Sugar Fasting, Lipid Profile, Liver Function Test,
Kidney Function Test, Urine (routine and microscopy), Stool
(routine and microscopy), electrocardiogram, Chest X‑ray
PA view and ultrasonography whole abdomen and pelvis)
were filled in the pro forma. The volunteers were instructed
to take four globules of the coded drug four times a day for a
maximum period of 3 days. Orientation training programs were
conducted for the staff, faculty and students of homoeopathic
medical colleges to educate them about the process of drug
proving and safety of proving substance before the initiation
of the study. However, as it was a double‑blind study, names
of proving substance were not disclosed. The provers were
asked to note down daily the details of their feelings/changes
in mental and/or physical state, after taking the coded drug in
“Prover’s Day Book Proforma”©.

If sign(s)/symptoms(s) appeared
•

The provers were asked to stop taking the drug/placebo

•

as soon as they felt any change or any sign(s) and/or
symptoms(s) developed during the trial
The provers noted down the sequence of the appearance
of new sign(s) and/or symptoms(s), their progress and
the number of doses after which such sign(s) and/or
symptoms(s) appeared, with date, time of onset and
duration for which they persisted
Any change in normal routine of the prover in respect of
daily habits pertaining to diet, living conditions etc., any
treatment taken was also noted in the Prover’s Day Book
Proforma.

After disappearance of sign(s) and/or symptom(s) produced
by the drug, the volunteer had to wait for a further period
of 30 days (wash out period) before starting the next phase
following the same dose schedule as stated above.
The symptoms recorded in “Prover’s Day Book Proforma”
were verified by the Proving Master and completed through
further interrogation with the provers in respect to their
location(s), sensation(s), modalities and concomitants,
extension of symptoms, causation, clinicopathological findings
and other treatment taken, if any, in “Symptoms Elaboration
Proforma.”
During the course of proving, the provers were referred for specific
laboratory investigation(s) to rule out any pathological cause of
appearance of symptom(s). Since laboratory tests were performed
to identify any correlation between the subjective and objective
changes during the course of proving, the expert opinion of the
honorary consultant(s) was obtained, wherever needed.

If no sign(s)/symptoms(s) appeared

The provers noted down “No Symptom” with date and time of
intake of the respective dose of the drug/placebo in “Prover’s
Day Book Proforma.”
Before commencing the administration of subsequent
potencies (subsequent Phase) of the drug, the provers remained
on a wash out period of 30 days and started taking next
potency following the same procedure as mentioned above,
till completion of all the doses/appearance of symptom. The
same procedure was followed for the 3rd phase. After the
completion of trial of all potencies, the provers underwent
Terminal (Post Trial) Medical Examination (TME), following
the same manner as done during PME.
On completion of all the phases of the drug proving, the
compilation of data recorded in “Prover’s Day Book
Proforma,” “Symptoms Elaboration Proforma,” “Pathological
Report Sheets” and “TME sheets,” was done by the Drug
Proving‑cum‑Data Processing Cell of the Council. After
decoding, the sign(s) and/or symptom(s) generated by the
provers kept on the drug were separated from those generated
by the provers kept on placebo.

Management of adverse effects

A vial of medicated globules of Camphora 30C was sent
with each quota to each center as “Antidote.” As per

Indian Journal of Research in Homoeopathy ¦ Volume 15 ¦ Issue 2 ¦ April-June 2021

79

[Downloaded free from http://www.ijrh.org on Thursday, August 26, 2021, IP: 243.33.235.79]
Mehra, et al.: Drug proving of Cuprum aceticum

recommendation by a group of experts, Camphora 30C was
used as an antidote. In case of prolonged or intensely disturbing
symptoms, antidote was to be used by the Proving Master after
consulting the medical expert.

Proving symptoms

The sign(s) and/or symptom(s) generated by verum (drug)
or control (placebo) on each prover are noted down for each
phase, number of doses after which each of the signs or
symptoms appeared and the duration for which they persisted.
The sign(s) and/or symptom(s) generated by verum group are
separated from those generated by provers of control group.
The sign(s) and/or symptom(s) which were produced by the
placebo in control and verum group provers are not taken into
consideration.

Statistical analysis

The consolidated standards of reporting trials[9] and Red Hot
guidelines[10] were adhered to report the outcome of the trial.
The compiled data of proving symptoms and the changes in the
laboratory investigations were analysed using IBM Statistical
Package for the Social Sciences (SPSS) version 20, USA for
Windows was used for all the data analysis.
Comparisons between Homoeopathy and placebo groups were
performed at baseline to assess randomization effect using
independent “t‑test” for the continuous variable and “Chi‑square
test” for the categorical variables. Further “descriptive
analysis” was done for the data with respect to the pathogenetic
effect (signs and/or symptoms) produced during trial.
To distinguish placebo effect and nocebo effect, intra and inter
prover analysis was done in both the groups.

Pathogenetic effects

Pathogenetic effects (Proving symptoms) are defined as all
changes in state of health and laboratory findings reported by
the provers during the Homoeopathic Pathogenetic Trial and
recorded in the final report. The incidence of pathogenetic
effects per prover is defined as the total number of findings
observed in verum group of the trial divided by the total
number of provers.[11]
Pathogenetic effects were deduced from:
i. Comparison of symptoms developed in the placebo phase
with symptoms during intervention phases (intra‑prover
comparison)
ii. Comparison of symptoms developed by provers on
control (for all phases) with provers on actual drug
trial (inter‑prover comparison).

and number of provers who developed symptoms during
the trial. The baseline information in both the groups was
comparable (P ≥ 0.05) and well matched as shown in Table 1.
Out of 50 enrolled provers, 42 provers underwent the TME. 06
provers dropped out from the verum group while 02 provers
dropped out from placebo group. The descriptive data analysis
was done for remaining 42 provers as per protocol.
During the pathogenetic trial, out of 34 provers who were
in verum group, only 12 (35%) provers reported symptoms
consequent upon the administration of the drug. In the
placebo group, five (31%) provers produced the symptoms.
The symptoms developed after the administration of both
the potencies, i.e., 6C and 30C. Out of 46 symptoms which
were produced by the provers of verum group in the 2nd and
3rd phases, 26 symptoms were produced in 6C potency [Table 2]
while 20 symptoms were produced in 30C potency [Table 3].
In 6C potency, majority of symptoms developed after the
administration of 10–12 doses while in 30C potency symptoms
developed after administration of 4–5 doses only.
The following proving symptoms appeared in both 6C and
30C potency:
1. Loquacity (talking about irrelevant things), did not want
to be interrupted, if interrupted feels like hitting
2. Bursting pain in the frontal region of the head
3. Stitching pain in right lower molar
4. Gripping, colicky pain in the abdomen
5. Dry cough
6. Stitching pain in lower extremities especially calf muscles
7. Fever.
Loquacity, stitching pain in right lower molar, stitching pain in
lower extremities especially calf muscles and fever symptoms
are reported by the same prover in both 6C and 30C potency.
They were reported singularly by different provers in the verum
group only. They were not observed in the placebo group or
the placebo phase of the verum group.
Analysis was also done considering the physical built,
physical generals and mental generals of the provers in the
verum group who have produced symptoms but no significant
similarities were found in these provers, which could have
been considered the constitutional symptoms. Further,
inter‑group analysis considering the above parameters were
done in the provers who have produced symptoms in the

Results
From three drug proving centers where the study was
conducted, a total of 76 volunteers were screened and 50
apparently healthy volunteers were enrolled as provers.
Of 50 provers, 34 were on verum and 16 were on placebo.
Figure 1 shows the flowchart of the number of volunteers
who underwent screening, enrolled, randomized in two groups
80

Figure 1: Flow chart of study participants
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Table 1: Baseline information
Variable

Homoeopathy (n=34)

Placebo (n=16)

P

Age (years)
23.8±4.1
23.6±3.7
0.794§
Gender, n (%)
Male
16 (47.1)
7 (43.8)
0.827¥
Female
18 (52.9)
9 (56.2)
BMI
21.5±3.01
22.28±4.54
0.473§
HB (g/dl)
12.98±1.58
13.03±1.58
0.895§
TLC
7465.3±896.1
7319.3±1371.7
0.654§
ESR (mm after 1 h)
11.44±8.63
11.31±6.48
0.958§
Fasting BS (mg/dl)
79.86±9.79
81.28±8.43
0.619§
Total cholesterol (mg/dl)
154.1±25.76
141.53±29.84
0.133§
SGOT (U/L)
16.55±6.85
16.94±5.18
0.843§
SGPT (U/L)
22.51±11.93
20.82±7.81
0.609§
Alkaline phosphatase
144.63±21.76
138.36±21.58
0.345§
Values are expressed in (%), mean±SD, §Independent t‑test, ¥Chi‑square test. BMI: Body mass index, SD: Standard deviation, HB: Hemoglobin, TLC: Total Leucocyte
Count, ESR: Erythrocyte Sedimentation Rate, SGPT: Serum glutamic-pyruvic transaminase, SGOT: Serum glutamic-oxaloacetic transaminase, BS: Blood Sugar

Table 2: Symptoms produced with 6C potency of Cu acet.
Location

Symptoms observed

Mind

Loquacity (talking about irrelevant things), didn’t want to be interrupted, if interrupted feels
like hitting
Vertigo
Vertigo; aggravation afternoon, amelioration evening
Head
Bursting pain in frontal region of head; aggravation night
Pain in head as if head would burst (10 am to12 noon); aggravation stooping
Dull, aching pain in the frontal region of the head with coryza; aggravation Walking, bending
forward, afternoon till night, amelioration pressure, after sleep
Eyes
Swelling of both lower eyelids, aggravation morning
Nose
Sneezing with watery nasal discharge; aggravation morning
Mouth
Aphthae on lower lip, white in color, with red margins, and burning pain; aggravation eating,
talking
Aphthae in mouth with burning pain, whitish in color, red in margin with dry tongue
Dryness of mouth with excessive thirst and desire for cold water
Teeth
Stitching pain in right lower molar; aggravation eating
Throat
Sore throat A/F exposure to dust; aggravation noon to evening, cold water, amelioration taking
tea, gargling by hot water
Stomach
Nausea with weakness; aggravation 9 am
Abdomen
Cutting pain in abdomen; aggravation eating
Aching pain in abdomen at 6 pm (umbilical region). Next day pain increased in intensity with
loose watery stool (3-4 times/day); aggravation eating
Gripping pain in abdomen with loose stool (3 times/day), associated with great thirst, loss of
appetite, and bitter taste
Rectum
Stool mixed with blood, burning sensation in rectum; amelioration cold application
Cough
Dry cough, aggravation night
Back
Aching pain in the nape of the neck from 2 pm to 7 pm; aggravation looking upwards. Next
day the intensity of symptom increased from the morning till the evening and continued for 2
more days
Dull aching pain with stiffness in lumbar region; aggravation afternoon till night, walking,
lying down, amelioration massaging
Extremities
Stitching pain in lower extremities especially calf muscles; aggravation night
Itching in the right leg, scratching leads to burning
Sleep
Sleeplessness
Fever
Fever with chills and body ache in the evening; aggravation cold weather
Skin
Small red macules on the left side of the neck and shoulder without itching for 8 days. Then
only on the neck since the 9th day and disappeared after 5 days
Small, red papular eruptions on the right arm and front of the neck, associated with itching and
burning; aggravation touch, night, amelioration rubbing
A/F: Ailments from
Indian Journal of Research in Homoeopathy ¦ Volume 15 ¦ Issue 2 ¦ April-June 2021

Doses

Symptom duration in days

12

3 days

12
12
12
2

10 days
7 days
2h
1 day

12
12
12

4 days
4 days
3 days

12
3
12
2

6 days
3 days
5 days
4h

12
12
11

10 days
5 days
2 days

12

7 days

2
12
10

5 days
1 day
4 days

2

1 day

12
10
12
12
12

6 days
1 day
5 days
1 day
14 days

12

6 days
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Table 3: Symptoms developed by 30C potency of Cu acet.
Location

Symptoms observed

Mind

Anger with irritability when contradicted; amelioration being alone. This is associated with
thoughts of committing suicide
Loquacity (talking about irrelevant things), did not want to be interrupted, if interrupted feels
like hitting
Bursting pain in head; aggravation night, amelioration pressure
Pain in head with feeling as if head would burst in small pieces associated with sleepiness;
aggravation bending forward
Bursting pain in frontal region of head; aggravation walking, noise, amelioration tight bandaging
Heaviness in both eyes followed by retro‑orbital pain with burning in eyes, aggravation after
studying. Next day lachrymation in both eyes with itching and puffiness around the eyes;
aggravation after studying
Coryza with watery nasal discharge; aggravation morning, night
Stitching pain in first right lower molar radiating to right ear; aggravation cold drink,
amelioration warm water
Heaviness and stinging pain in whole abdomen; aggravation eating, amelioration pressure
Heaviness in the epigastric region
Colicky pain in abdomen; aggravation eating, drinking, amelioration pressure, bending forward
Hard, unsatisfactory stool
Dry cough with scanty, white expectoration associated with throbbing pain in head on coughing,
heaviness in head throughout the day and fever (99.6°F). However, cough symptoms continued
for the next 2 days and fever again on the third day (99°F)
Cutting pain in lumbar region; aggravation lying down, walking, amelioration sitting, warmth
Stitching pain in claves; aggravation walking, amelioration pressure
Stitching pain in both legs; aggravation night, amelioration pressure
Sleepiness
Fever (102°F) associated with vomiting (once of undigested food particles), vertigo, restlessness,
weakness, reduced appetite, and disturbed sleep during day and night
Weakness of whole body associated with vertigo
Burning sensation in the whole body

Head

Eyes
Nose
Teeth
Abdomen

Rectum
Cough
Back
Extremities
Sleep
Fever
Generalities

verum group and control group but no distinct similarities or
dissimilarities were found.
A comprehensive qualitative symptom profile of intervention
group, control group, and former homoeopathic proving
symptoms found in the literature [Table 4] reflect that:
• Symptoms were generated in intervention group and
were placed in regional spheres (following the Schema
Repertory of the Homoeopathic Materia Medica by
J. T. Kent[12]) of Mind, Vertigo, Head, Eyes, Nose, Mouth,
Throat, Abdomen, Rectum, Cough, Back, Extremities,
Sleep and Skin in the present study and were found to
have striking similarities to the symptoms present in the
homoeopathic literature[3,13,14]
• In addition to the above, symptoms were also generated in
intervention group in regional spheres of teeth, stomach,
fever, and generalities.
A brief summarization of the main symptoms observed which
are also mentioned in the homoeopathic literature is as follows:
1. Anger and attacks of rage
2. Violent pain in the frontal region of the head
3. Eyelids swollen
4. Dryness of mouth with thirst for cold water
5. Sore throat
6. Colicky, gripping pain in the abdomen and diarrhea
7. Dry cough with tearing/throbbing pain in the head
82

Doses

Symptom duration in days

5

4 days

5

4 days

4
5

5 day
6 day

5
4

1 day
5 days

4
4

3 days
2 days

4
5
5
5
10

3 day
1 day
1 day
4 days
4 days

4
4
4
4
5

3 days
4 days
3h
1 days
3 days

4
5

5 days
2 days

8.

Pain in nape of neck, aggravation (agg.) looking upward
or bending head backward
9. Pain and cramp in the extremities especially calf muscles
10. Complete sleeplessness in 6C and sleepiness in 30C
potency.
The incidence of pathogenetic effects in this study has been
found to be 1.35.
Placebo symptoms developed during the trial are placed in
Table 5.

Discussion
In the present study, when the symptoms generated in
the verum group, placebo group and the earlier proving
symptoms available in the homoeopathic literature were
compared, it was found that marked mental symptoms were
elicited in this proving and many symptoms were similar to
those mentioned in the literature. Characteristic symptoms
were produced related to head, eye, mouth, abdomen,
rectum, cough, back and extremities, sleep and fever with
marked modalities, and associated symptoms. Well‑defined
skin symptoms with finer details were observed in
comparison with a few vague symptoms mentioned in the
homeopathic literature.
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Table 4: Qualitative symptom profiles of intervention group, control group, and former Homoeopathic drug proving
symptoms
Section

Placebo (C)

Mind

Vertigo

Head

Vertigo with heaviness of head
Vertigo with malaise and
low BP‑110/60 mm Hg;
aggravation evening, lying
down and next day BP‑110/50
mm Hg; aggravation evening
Vertigo with dizziness and
drowsiness; amelioration lying
down
Heaviness in head;
aggravation evening,
amelioration rest
Dull aching pain in frontal
region of head with
drowsiness and vertigo;
aggravation 3 pm to 5 pm,
amelioration placing hand
on forehead. Next day same
symptom persisted for whole
day
Aching pain in frontal and
supra‑orbital region of
head; aggravation motion,
amelioration pressure
Bursting pain at vertex
extending to frontal region;
aggravation night. Next day
onwards associated with
sleepiness
Heaviness in occipital region
of head (10 am to 6 pm).
Next day aching pain in head.
Heaviness in the occipital
region of the head reappeared
after 4 days and continued for
3 days
Heaviness of the head
Aching pain in the frontal
region of the head extending
to vertex; aggravation after
waking. This was associated
with vomiting (two episodes)
on the 2nd day

Cuprum
aceticum 6C

Cuprum aceticum
30C

Loquacity (talking
about irrelevant
things), didn’t
want to be
interrupted, if
interrupted feels
like hitting

Anger with irritability
when contradicted,
amelioration
being alone. This
is associated
with thoughts of
committing suicide
Loquacity (talking
about irrelevant
things), did not want
to be interrupted, if
interrupted feels like
hitting

Vertigo,
aggravation
afternoon,
amelioration
evening

Bursting pain in
frontal region of
head; aggravation
night
Pain in head as
if head would
burst (10 am
to 12 noon);
aggravation
stooping
Dull, aching
pain in frontal
region of head
with coryza;
aggravation
walking,
bending forward,
afternoon
till night,
amelioration
pressure, after
sleep

Bursting pain in
head; aggravation
night, amelioration
pressure
Pain in head with
feeling as if head
would burst in small
pieces associated
with sleepiness;
aggravation bending
forward
Bursting pain in
frontal region of
head; aggravation
walking, noise,
amelioration tight
bandaging

Common symptoms
of verum and
placebo groups

Profile of cuprum
aceticum by previous
homoeopathic provings
Extreme anguish[13]
Attacks of rage[3]
Talks all the time[3]
Disconnected, delirious
talking[3]

Vertigo

Vertigo[3]
Vertigo, marked
and persistent, with
stupefaction[14]

Dull aching pain in
frontal region of head

Headache in nearly all
cases. Very violent,
especially in the forehead
and vertex, becoming
less after 1 or 2 days,
sometimes however
returning[3]
Sensation of pressure and
heaviness in the head[3]
Throbbing pain in whole
head. Beating headache.
Violent headache[3]
Violent pain in the frontal
region. Violent pains in
the forehead[3]
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Table 4: Contd...
Section

Eye

Nose

Face

Placebo (C)

Aching pain in whole head
with vertigo, sleeplessness
and nausea (9 am to 12 noon);
amelioration by pressing
Aching pain in left side of
head associated with heaviness
of whole head and over
eyebrows (12 noon to 4 pm);
amelioration by pressing, after
sleep
Aching pain in occipital
region of head; aggravation
moving head in lying position,
amelioration drinking tea
Bursting pain in occipital
region radiating to eyeballs;
aggravation pressure, night
Pain in bi‑temporal region
with sensation of heaviness;
aggravation opening eyes,
talking, amelioration closing
eyes
Left sided headache at 2: 30
pm for 2-3 min
Swelling of both lower eye
lids for 2 days. After a gap of
1 day felt heaviness in eyes as
if swollen which persisted for
4 days

Sneezing (5-6 bouts) with
watery nasal discharge and
lachrymation associated with
retro‑orbital pain
Watery nasal discharge with
sneezing
Coryza with watery nasal
discharge and sneezing;
aggravation morning, cold
air, amelioration afternoon,
evening
Watery nasal discharge with
right‑sided frontal headache at
5 pm for 5 min
Red‑colored papule on right
cheek with throbbing pain

Cuprum
aceticum 6C

Cuprum aceticum
30C

Common symptoms
of verum and
placebo groups

Profile of cuprum
aceticum by previous
homoeopathic provings

Swelling of both
lower eyelids;
aggravation
morning

Heaviness in both
eyes followed by
retro‑orbital pain
with burning in eyes;
aggravation after
studying. Next day
lachrymation in both
eyes with itching and
puffiness around the
eyes; aggravation
after studying
Coryza with watery
nasal discharge;
aggravation morning,
night

Swelling of both
lower eyelids

Eyelids very red and
swollen, so that they
could hardly be opened[3]

Sneezing with watery
nasal discharge

Very violent fluent
coryza, with lachrymation
and smarting in the eyes[3]

Sneezing with
watery nasal
discharge;
aggravation
morning
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Table 4: Contd...
Section

Placebo (C)

Cuprum
aceticum 6C

Mouth

Burning sensation in the
mouth with red discoloration
of buccal mucosa and ulcer on
edge and tip of tongue

Aphthae on
lower lip, white
in colour, with
red margins, and
burning pain;
aggravation
eating, talking
Aphthae in mouth
with burning pain,
whitish in colour,
red in margin with
dry tongue
Dryness of mouth
with excessive
thirst and desire
for cold water
Stitching pain in
right lower molar;
aggravation eating

Teeth

Throat

Stomach

Rawness in throat
Pain in throat (soreness with
hoarseness) with general
weakness, tiredness and
heat in palms and body;
aggravation on swallowing
Soreness in throat with dryness
and difficulty in eating food
Soreness of throat with
tingling sensation
Soreness in throat with
excessive salivation and
difficulty in swallowing
Soreness in throat associated
with dryness of mouth
and malaise; aggravation
swallowing solid food
Vomiting of mucus in morning
followed by nausea
Nausea for 2 days. Reappeared
after 7 days for 2 days
Heaviness in epigastric region
with nausea and bloating of
abdomen; aggravation evening
till mid night
Burning pain in epigastric
region, associated with nausea
and belching; aggravation
lying down, amelioration
after vomiting (thrice) of
undigested food
Nausea with sensation
of obstruction in throat;
aggravation after dinner
Vomiting of food eaten (twice
at 6:30 am and 6 pm) with
bleeding from left nostril;
aggravation after breakfast

Cuprum aceticum
30C

Common symptoms
of verum and
placebo groups

Profile of cuprum
aceticum by previous
homoeopathic provings
Dryness of the mouth[3]
Great thirst for cold
water[3]

Stitching pain in first
right lower molar
radiating to right
ear; aggravation cold
drink, amelioration
warm water

Sore throat A/F
exposure to dust;
aggravation
noon to evening,
cold water,
amelioration
taking tea,
gargling by hot
water

Sore throat

Nausea with
weakness;
aggravation 9 am

Nausea

Inflammation of the
throat, preventing
swallowing[3]
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Table 4: Contd...
Section

Placebo (C)

Cuprum
aceticum 6C

Cuprum aceticum
30C

Common symptoms
of verum and
placebo groups

Profile of cuprum
aceticum by previous
homoeopathic provings

Abdomen

Aching pain in abdomen
with heaviness; aggravation
morning
Aching pain in epigastric
region with drowsiness;
aggravation before and after
eating
Cutting pain in epigastric
region aggravation 12 noon to
2 pm. Next day aching pain
in abdomen for same timings.
After a gap of 1 day aching
pain in abdomen reappeared
and continued for 4 days
Aching pain in right
hypochondrium with dark
colored stool in morning;
amelioration pressure.
Symptom continued whole
day but intensity of pain much
reduced when woke up next
day and subsided after stool
Macular eruption with itching
on abdomen turned into boils
next day
Aching pain in right
hypochondrium; aggravation 9
am to 1 pm
Cutting pain in abdomen
associated with diminished
appetite and increased thirst
for cold water; aggravation
2 pm
Aching pain in lower
abdomen; aggravation lying
on back, amelioration lying on
abdomen
Aching pain in both
hypochondrium (6 pm to 9
pm)
Bleeding per rectum while
passing soft stool
Fruity smell in stool (one
episode)

Cutting pain
in abdomen;
aggravation eating
Aching pain in
abdomen at 6
pm (umbilical
region). Next day
pain increased
in intensity with
loose watery
stool (3-4 times/
day); aggravation
eating
Gripping pain
in abdomen
with loose
stool (3 times/
day), associated
with great thirst,
loss of appetite,
and bitter taste

Heaviness and
stinging pain in
whole abdomen;
aggravation eating,
amelioration pressure
Heaviness in
epigastric region
Colicky pain
in abdomen;
aggravation
eating, drinking,
amelioration
pressure, bending
forward

Aching pain in
abdomen
Cutting pain in
abdomen

Tearing‑cutting pain in
the abdomen[3]
Occasional griping pains
in abdomen[3]
Profuse diarrhoea; the
stools continues for a
long time with tenesmus
and prostration, only
relieved after 8 days[3]
Pain in region of
stomach[3]
Violent colic in stomach
and bowels[3]

Stool mixed
with blood,
burning sensation
in rectum;
amelioration cold
application

Hard, unsatisfactory
stool

Bleeding per rectum

Smarting at the anus after
stoo[3]

Rectum

Urine

Profuse urination (without
reason)
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Table 4: Contd...
Section

Placebo (C)

Cuprum
aceticum 6C

Cuprum aceticum
30C

Common symptoms
of verum and
placebo groups

Profile of cuprum
aceticum by previous
homoeopathic provings

Cough

Dry cough associated
with running nose and
fever (100°F); amelioration
warm drinks. No fever for
next 2 days but heat of body
present (URTI)
Cough with mucoid
expectoration associated with
coryza and heaviness in chest;
aggravation morning, while
sleeping, amelioration warm
drinks, warm room
Dry cough with pain in
throat, nasal obstruction and
yellowish nasal discharge;
aggravation morning, daytime,
after eating, cold things
Itching on sub‑mammary
region, scratching leads
to burning; amelioration
undressing
Stitching pain in lumbar
region with restlessness,
extending towards
right side; amelioration
massaging (temporary relief)

Dry cough;
aggravation night

Dry cough with
scanty, white
expectoration
associated with
throbbing pain in
head on coughing,
heaviness in head
throughout the day
and fever (99.6°F).
But cough symptoms
continued for next
2 days and fever
again on the third
day (99°F)

Dry cough

Frequent, violent, dry
cough, with tearing pain
in the head; the cough
was followed by violent
pulsation of the heart,
lasting several min; at
this time the anxiety
and pressure in the chest
returned, especially while
sitting; cough came on at
night between 11 and 1[3]

Aching pain in
nape of neck
from 2 pm to 7
pm; aggravation
looking upwards.
Next day the
intensity of
symptom
increased from
morning till
evening and
continued for 2
more days
Dull aching pain
with stiffness in
lumbar region;
aggravation
afternoon till
night, walking,
lying down,
amelioration
massaging
Stitching pain in
lower extremities
especially
calf muscles;
aggravation night
Itching in right
leg, scratching
leads to burning

Cutting pain in
lumbar region;
aggravation lying
down, walking,
amelioration sitting,
warmth

Pain in lumbar region

Lancinating pain at the
nape of neck, on bending
head backwards[3]
Pain in the loins[3]

Stitching pain in
calves; aggravation
walking, amelioration
pressure
Stitching pain in both
legs; aggravation
night, amelioration
pressure

Pain in lower
extremities

Pain and cramp in the
extremities[3]
Violent cramping,
paroxysmal, in the
calves[3]
Violent drawing and
tension in limbs[14]

Chest

Back

Extremities

Aching pain in lower
extremities; aggravation night
Stitching pain with stiffness
and difficulty in movement of
right shoulder (4 pm to 8 pm)
Tearing, bony pain in left
forearm with inability to hold
anything (8 am to 11 am)
Aching pain in right leg over
shin; aggravation walking for
10 days. This was associated
with numbness in both lower
extremities; aggravation sitting
for 5-10 min with folded legs
which lasted for 1 more day
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Table 4: Contd...
Section

Placebo (C)

Sleep

Fever

Skin

Fever (101°F) with chills
associated with sore throat
and watery discharge from
nose; amelioration warm
application, warm drinks,
gargles. On 3rd day only
watery nasal discharge
Fever (99.8°F) with body ache
and malaise
Fever with bodyache, nausea
and dizziness started in
evening and persisted till
morning
Itching followed by redness
and eruptions (wheal
formation) on whole body
associated with sleepiness
on and off whole night;
aggravation after taking bath.
Itching reappeared around 1
pm with small red eruptions
on the hands. Same symptoms
reappeared at 10 pm with
sleepiness and continued till
2 days
Eruptions with itching on
lateral side of both elbows;
aggravation 4 pm and 8 pm,
amelioration morning
Itching whole body
Itching on lateral sides of both
arms just below shoulders
aggravation 9 to 9:30 pm for
3 days. On 4th day eruptions
also appeared at the same site
with itching which are hard
to touch. On the 11th day,
skin become hyperpigmented
on the spot of eruption while
itching continued, then turned
into wheal with occasional
bleeding on scratching
Itching all over body with
macular eruptions which are
red in colour
Itching with macular eruptions
on lateral side of left arm just
below the shoulder. Next day
wheal formation; aggravation
after undressing (9 pm to 1
am). On 4th day only itching
remained

Cuprum
aceticum 6C

Cuprum aceticum
30C

Sleeplessness
lasting 5 days

Sleepiness

Fever with chills
and body ache
in the evening;
aggravation cold
weather

Fever (102°F)
associated with
vomiting (once of
undigested food
particles), vertigo,
restlessness,
weakness, reduced
appetite and disturbed
sleep during day and
night

Small red macules
on the left side
of the neck and
shoulder without
itching for 8 days.
Then only on
neck since the
9th day and
disappeared after
5 days
Small, red papular
eruptions on
the right arm
and front of the
neck, associated
with itching
and burning;
aggravation
touch, night,
amelioration
rubbing

Common symptoms
of verum and
placebo groups

Profile of cuprum
aceticum by previous
homoeopathic provings
Complete sleeplessness,
frequently lasting three or
4 days[3]
Great sleepiness[3]

Fever with chills and
fever with bodyache

Eruptions with
itching

Eruptions on the skin[3]
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Table 4: Contd...
Section

Placebo (C)

Cuprum
aceticum 6C

Cuprum aceticum
30C

Generalities

Weakness and does not
Weakness of
want to talk to anyone. After
whole body
2 days interval weakness of
associated with
whole body reappeared with
vertigo
sensation of fatigue, malaise,
Burning sensation
wants to lie down and does not
in whole body
want to talk to anyone
General weakness and
tiredness of whole body;
aggravation evening
Weakness
Weakness with fatigue and
malaise with low BP (110/50
mm Hg). Next day BP=90/60
mm Hg
URTI: Upper respiratory tract infection, BP: Blood pressure

Common symptoms
of verum and
placebo groups

Profile of cuprum
aceticum by previous
homoeopathic provings

Weakness of whole
body

Table 5: Placebo symptoms developed during the trial
Each one of these symptoms mentioned below were developed and reported by single prover
Location

Symptoms observed

Vertigo

Vertigo with heaviness of head
Vertigo with malaise and low BP‑110/60 mm Hg; aggravation evening, lying down and
next day BP‑110/50 mm Hg; aggravation evening
Vertigo with dizziness and drowsiness, amelioration lying down
Heaviness in head; aggravation evening, amelioration rest
Dull aching pain in frontal region of head with drowsiness and vertigo; aggravation 3 pm
to 5 pm, amelioration placing hand on forehead. Next day same symptom persisted for
whole day
Aching pain in frontal and supra‑orbital region of head; aggravation motion, amelioration
pressure
Bursting pain at vertex extending to frontal region; aggravation night. Next day onwards
associated with sleepiness
Heaviness in occipital region of head (10 am to 6 pm). Next day aching pain in head.
Heaviness in occipital region of head reappeared after 4 days and continued for 3 days
Heaviness of head
Aching pain in frontal region of head extending to vertex; aggravation after waking. This
was associated with vomiting (two episodes) on 2nd day
Aching pain in whole head with vertigo, sleeplessness and nausea (9 am to 12 noon);
amelioration by pressing
Aching pain in left side of head associated with heaviness of whole head and over
eyebrows (12 noon to 4 pm); amelioration by pressing, after sleep
Aching pain in occipital region of head; aggravation moving head in lying position,
amelioration drinking tea
Bursting pain in occipital region radiating to eyeballs; aggravation pressure, night
Pain in bi‑temporal region with sensation of heaviness; aggravation opening eyes, talking,
amelioration closing eyes
Left sided headache at 2:30 pm for 2-3 min
Swelling of both lower eye lids for 2 days. After a gap of 1 day felt heaviness in eyes as if
swollen for 4 days
Sneezing (5-6 bouts) with watery nasal discharge and lachrymation associated with
retro‑orbital pain
Watery nasal discharge with sneezing
Coryza with watery nasal discharge and sneezing; aggravation morning, cold air,
amelioration afternoon, evening
Watery nasal discharge with right sided frontal headache at 5 pm for 5 min

Head

Eye
Nose

Doses

Symptom duration in days

6
8

3 days
2 days

4
12
6

6 days
3h
2 days

12

3 days

8

10 days

5

5 days

4
4

1 day
2 days

12

3h

12

4h

3

2 days

7
8

5h
4 days

6
8

2-3 min
6 days

8

9 days

8
8

3 days
3 days

8

5 min
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Table 5: Contd...
Each one of these symptoms mentioned below were developed and reported by single prover
Location

Symptoms observed

Mouth

Burning sensation in the mouth with red discoloration of buccal mucosa and ulcer on edge
and tip of tongue. Dryness of mouth
Red coloured papule on right cheek with throbbing pain
Rawness in throat
Pain in throat (soreness with hoarseness) with general weakness, tiredness and heat in
palms and body; aggravation on swallowing
Soreness in throat with dryness and difficulty in eating food
Soreness of throat with tingling sensation
Soreness in throat with excessive salivation and difficulty in swallowing
Soreness in throat associated with dryness of mouth and malaise; aggravation swallowing
solid food
Vomiting of mucus in morning followed by nausea
Nausea for 2 days. Reappeared after 7 days for 2 days
Heaviness in epigastric region with nausea and bloating of abdomen; aggravation evening
till mid night
Burning pain in epigastric region, associated with nausea and belching; aggravation lying
down, amelioration after vomiting (thrice) of undigested food
Nausea with sensation of obstruction in throat; aggravation after dinner
Vomiting of food eaten (twice at 6:30 am and 6 pm) with bleeding from left nostril;
aggravation after breakfast
Aching pain in abdomen with heaviness; aggravation morning
Aching pain in epigastric region with drowsiness; aggravation before and after eating
Cutting pain in epigastric region aggravation 12 noon to 2 pm. Next day aching pain in
abdomen for same timings. After a gap of 1 day aching pain in abdomen reappeared and
continued for 4 days
Aching pain in right hypochondrium with dark colored stool in morning; amelioration
pressure. Symptom continued whole day but intensity of pain much reduced after waking
up next day and subsided after stool
Macular eruption with itching on abdomen turned into boils next day
Aching pain in right hypochondrium; aggravation 9 am to 1 pm
Cutting pain in abdomen associated with diminished appetite and increased thirst for cold
water; aggravation 2 pm
Aching pain in lower abdomen; aggravation lying on back, amelioration lying on abdomen
Aching pain in both hypochondrium (6 pm to 9 pm)
Bleeding per rectum while passing soft stool
Fruity smell in stool (one episode)
Profuse urination (without reason)
Dry cough associated with running nose and fever (100°F); amelioration warm drinks. No
fever for next 2 days but heat of body present (URTI)
Cough with mucoid expectoration associated with coryza and heaviness in chest;
aggravation morning, while sleeping, amelioration warm drinks, warm room
Dry cough with pain in throat, nasal obstruction and yellowish nasal discharge; aggravation
morning, daytime, after eating, cold things
Itching on sub‑mammary region, scratching leads to burning; amelioration undressing
Stitching pain in the lumbar region with restlessness, extending toward right side;
amelioration massaging (temporary relief)
Aching pain in lower extremities; aggravation night
Stitching pain with stiffness and difficulty in the movement of the right shoulder (4 pm to
8 pm)
Tearing, bony pain in the left forearm with inability to hold anything. (8 am to 11 am)
Aching pain in the right leg over shin; aggravation walking for 10 days. This was
associated with numbness in both lower extremities; aggravation sitting for 5-10 min with
folded legs which lasted for 1 more day

Face
Throat

Stomach

Abdomen

Rectum
Stool
Urine
Cough

Chest
Back
Extremities

Doses

Symptom duration in days

11

4 days

8
6
6

15 days
6 days
4 days

6
4
11
7

1 day
5 days
4 days
3 days

8
8
4

2 days
4 days
1 day

12

1 day

4
4

2 days
1 day

12
6
8

3h
2 days
6 days

12

2 days

5
5
8

2 days
4h
3 days

4
7
4
5
4
12

3 days
3h
2 days
1 day
30 days
3 days

4

3 days

3

5 days

4
8

6 days
4 days

8
6

4 days
4h

3
8

3h
11 days
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Table 5: Contd...
Each one of these symptoms mentioned below were developed and reported by single prover
Location

Symptoms observed

Fever

Fever (101◦ F) with chills associated with sore throat and watery discharge from nose;
amelioration warm application, warm drinks, gargles. On the 3rd day, only watery nasal
discharge
Fever (99.8°F) with body ache and malaise
Fever with body ache, nausea, and dizziness started in the evening and persisted till the
morning.
Skin
Itching followed by redness and eruptions (wheal formation) on whole body associated
with sleepiness on and off whole night; aggravation after taking bath. Itching reappeared
around 1 pm with small red eruptions on the hands. Same symptoms reappeared at 10 pm
with sleepiness and continued till 2 days
Eruptions with itching on lateral side of both elbows; aggravation 4 pm and 8 pm,
amelioration morning
Itching whole body
Itching on the lateral sides of both arms just below shoulders aggravation 9 to 9:30 pm
for 3 days. On the 4th day, eruptions also appeared at the same site with itching which are
hard to touch. On the 11th day, skin become hyperpigmented on the spot of eruption while
itching continued, then turned into wheal with occasional bleeding on scratching
Itching all over the body with macular eruption which are red in color
Itching with macular eruption on the lateral side of the left arm just below the shoulder.
Next day wheal formation; aggravation after undressing (9 pm to 1 am). On the 4th day,
only itching remained
Generalities
Weakness and does not want to talk to anyone. After 2 days interval weakness of whole
body reappeared with sensation of fatigue, malaise, wants to lie down, and does not want to
talk to anyone
General weakness and tiredness of whole body; aggravation evening
Weakness
Weakness with fatigue and malaise with low BP (110/50 mm Hg). Next day BP=90/60
mm Hg
URTI: Upper respiratory tract infection, BP: Blood pressure

Certain symptoms developed during the proving trial were
quite similar to those found in previous literature. Thus, it
can be considered as a characteristic for this drug. However,
there have been additional findings as well in a few of
these symptoms which need to be clinically verified. A few
symptoms which are overlapping in both the groups could be
due to the nocebo effect or due to confounding factors such
as alteration in weather, food or regimen. Although adequate
efforts were made to rule out such effects by proper record
keeping, these can’t be ruled out completely. The pathogenetic
findings of this drug need further verification by using it for
therapeutic purposes in the patients reporting with similar
symptoms.
In one of the articles, Dr. Teut[15] has mentioned that ‘placebo
proving occasionally seem to produce similar symptoms
to the proving symptoms, thus casting further doubt on
the use of this medium in proving’ and has attributed it to
nocebo effect. A nocebo response is explained as subject’s
own negative expectations and/or negative suggestions
from therapists/clinical staff in the absence of any treatment.
Nocebo phenomena are generally explained by Pavlovian
conditioning and expectations induced by verbal information
and suggestions. In this trial also nocebo phenomenon can be
considered and apart from the individual’s own perception,

Doses

Symptom duration in days

12

3 days

10
11

4 days
1 day

12

4 days

12

5 days

5
12

6 days
15 days

7
12

12 days
4 days

8

3 days

3
8
8

4h
1 day
4 days

this can be attributed to the discussion which usually takes
place among the students of homoeopathic colleges who are
the participants in the study. This poses a limitation as it is
difficult to keep a check on them for not discussing or sharing
the experiences. The massive number of symptoms developed
in the control group could be considered because of such
discussions among the students.
There are certain other limitations in the study apart from the
nocebo effect; like no defined parameters for the classification
of characteristic symptoms and less number of provers which
may be addressed in future studies.

Conclusion
The pathogenesis of the Cu acet. found in this study has
produced symptoms which were already noted in the
homoeopathic literature and there are many symptoms which
are new. These signs and symptoms need to be subjected to
clinical verification study for confirming their therapeutic
utility. This will further enhance the scope and utility of this
drug by the profession.
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D;wIje ,lsfVde dk gksE;ksiSfFkd jksxtud iSFkkstsusfVd ijh{k.k% ,d cgqdsfUnzd] Mcy - & CykbaM ;kn`fPNd] Iykflcks fu;af=r ijh{k.k
i`‘BHkwfe% ;|fi D;wIje esVsfyde dk y{k.k foKku csgn foLr`r gS] blds vU; {kkj viw.kZ :i ls fl) gSaA vr%] D;wIje ,lsfVde ds fy,
gksE;ksiSfFkd jksxtud iSFkkstsusfVd ijh{k.k fd;k x;k FkkA mn~ns”;% LoLFk euq”; izwolZ ij gksE;ksiSfFkd izHkkoksa esa D;wIje ,lsfVde ds izfr
iSFkstsusfVd izfrfØ;k dk lkj fudkyukA lkefxz;k¡ ,oa i)fr;k¡% dsUnzh; gksE;ksiSfFkd vuqla/kku laLFkku ¼lhlhvkj,p½ ds rhu dsUnzksa ij ,d
cgq&dsfUnzd Mcy& CykbaM ;kn`fPNd] Iykflcks fu;af=r]ijh{k.k lapkfyr fd;k x;k FkkA iwoZ&ijh{k.k fpfdRlh; tk¡p dks lapkfyr djus ds
i’pkr~ pqus x, 50 lacaf/kr LoLFk izwolZ ij izwfoax v/;;u lapkfyr fd;k x;kA lHkh izwolZ dks ijh{k.k ds izFke pj.k ds nkSjku Iykflcks nh xbZ
FkhA vxys nks pj.kksa esa] ;kn`fPNdhdj.k ds i’pkr~] D;wIje ,lsfVde dks gLr{ksih; lewg esa ¼,u ¾ 34½] rFkk Iykflcks lewg esa ¼,u ¾ 16½ 60
lh ,oa 30 lh izHkkoksa esa O;ofLFkr fd;k x;k FkkA D;wIje ,lsfVde ls mikftZr izHkkfor vkadM+ksa dks v/;;u &lg&vk¡dM+k izØe.k izdks"B esa
ladfyr ,oa ewY;kafdr fd;k x;k FkkA ifj.kke% 34 izwolZ esa ls tks okLrfod nok ijh{k.k ij Fks] dsoy 12 izwolZ us gh y{k.kksa dks O;Dr fd;k FkkA
30 lh ,oa 200lh izHkko'khyrk esa Øe'k% 26 ,oa 20 y{k.k O;Dr fd, x, FksA fu"d"kZ% v/;;u ijh{k.k ds nkSjku izkIr gqbZ iSFkkstsusfVd izfrfØ;k
us D;wIje ,lsfVde gksE;ksiSfFkd nok ds bLrseky dh laHkkouk dks c<+k fn;k gSA bl ijh{k.k esa mikftZr y{k.kksa dh cgqewY;rk uSnkfud lR;kiu
djus ij vkSj T;knk c<+sxhA

Essai homéopathique pathogénétique de Cuprum aceticum: essai multicentrique, en double-aveugle, randomisé et
contrôlé par placebo
Contexte: Bien que la symptomatologie de Cuprum metallicum soit assez vaste, ses autres sels ont des preuves fragmentaires.
Ainsi, un essai pathogénique homéopathique pour Cuprum aceticum a été entrepris. Objectif: Provoquer la réponse pathogénique
à Cuprum aceticum en puissances homéopathiques sur des prouveurs humains en bonne santé. Matériels et méthodes: Un
essai multicentrique randomisé en double-aveugle, contrôlé par placebo, a été mené dans trois centres du Conseil central pour
la recherche en homéopathie (CCRH). L’épreuve a été menée sur 50 prouveurs relativement en bonne santé sélectionnés après
avoir effectué l’examen médical préalable au procès. Tous les prouveurs ont été donnés un placebo au cours de la première
phase de l’essai. Au cours des deux phases suivantes, Cuprum aceticum a été administré à des concentrations de 6C et 30C,
dans le groupe d’intervention (n=34); et placebo dans le groupe placebo (n=16), après randomisation. Les données probantes
ainsi générées sur Cuprum aceticum ont été compilées et analysées dans la cellule d’épreuve-cum-traitement des données.
Résultat: Sur les 34 prouveurs ayant participé à un essai de médicament, seuls 12 témoins ont manifesté des symptômes. 26
et 20 symptômes ont été manifestés respectivement à puissance 30C et 200C. Conclusion: La réponse pathogénique suscitée
au cours de l’essai d’épreuve élargit le champ d’utilisation du médicament homéopathique Cuprum aceticum. Les symptômes
générés dans cet essai auront plus de valeur lorsqu’ils seront vérifiés cliniquement.

Indian Journal of Research in Homoeopathy ¦ Volume 15 ¦ Issue 2 ¦ April-June 2021

93

[Downloaded free from http://www.ijrh.org on Thursday, August 26, 2021, IP: 243.33.235.79]
Mehra, et al.: Drug proving of Cuprum aceticum

Ensayo patogenético homeopático de Cuprum aceticum: Ensayo multicéntrico, doble ciego, aleatorizado, controlado
con placebo
Fundamento: Aunque la sintomatología de Cuprum metallicum es bastante extensa, sus otras sales tienen pruebas fragmentarias.
Así, se realizó un ensayo patogenético homoeopático para Cuprum aceticum. Objetivo: Para obtener la respuesta patogénica
a Cuprum aceticum en potencias homeopáticas en demostradores humanos sanos. Materiales y métodos: Se llevó a cabo un
ensayo multicéntrico doble ciego aleatorizado, controlado con placebo, en tres centros del Consejo Central para la Investigación
en Homeopatía (CCRH). Se realizaron pruebas en 50 probadores relativamente sanos seleccionados después de realizar el
examen médico previo al ensayo. Todos los probadores recibieron placebo durante la primera fase del ensayo. En las dos fases
siguientes, Cuprum aceticum se administró en potencias 6C y 30C, en el grupo intervención (n=34); y placebo en el grupo
placebo (n=16), después de la aleatorización. Los datos de prueba así generados en Cuprum aceticum fueron compilados y
analizados en la celda de procesamiento de pruebas y datos. Resultado: De 34 probadores que estaban en ensayo real de
la droga, solamente 12 probadores manifestaron síntomas. 26 y 20 síntomas fueron manifestados en potencia 30C y 200C
respectivamente. Conclusión: La respuesta patogenética que se produjo durante el ensayo clínico de prueba amplía el alcance
del uso de la medicina homeopática Cuprum aceticum. Los síntomas generados en este ensayo tendrán más valor cuando se
verificen clínicamente.

Homöopathische pathogenetische Studie an Cuprum aceticum: Eine multizentrische, doppelblinde, randomisierte,
placebokontrollierte Studie
Hintergrund: Obwohl die Symptomatik von Cuprum metallicum ziemlich groß ist, haben seine anderen Salze fragmentarische
Beweise. Daher So wurde die homöopathische pathogenetische Studie für Cuprum aceticum aufgenommen. Ziel: Die
pathogenetische Reaktion auf Cuprum aceticum in homöopathischen Potenzen auf gesunde menschliche Provers hervorzurufen.
Um die pathogenetische Reaktion auf Cuprum aceticum in homöopathischen Potenzen bei gesunden menschlichen Prüfern
auszulösen. Materialien und Methoden: Eine multizentrische, randomisierte, placebokontrollierte Doppelblindstudie mit
mehreren Zentren wurde an drei Zentren des Central Council for Research in Homöopathy (CCRH) durchgeführt. Der Nachweis
wurde an 50 relativ gesunden Testern durchgeführt, die nach Durchführung der medizinischen Voruntersuchung ausgewählt
wurden. Alle Prüfer Prover erhielten in der ersten Phase der Studie ein Placebo. In den nächsten zwei Phasen, Cuprum aceticum
wurde in den Potenzen 6C-und 30C-Potenzen in der Intervention verabreicht gruppe (n=34); und Placebo in der Placebogruppe
(n=16) nach Randomisierung. Die auf Cuprum aceticum so erzeugten Nachweisdaten wurden in der Proving-cum-data
processing cell zusammengestellt und analysiert. Ergebnisse Ergebnis: Von 34 Probanden, die an einer Arzneimittelprüfung
Wirkstoffstudie teilnahmen, zeigten nur 12 Probanden Symptome. 26 und 20 Symptome zeigten sich in 30C bzw. 200C
Potenz. Schlussfolgerung: Die pathogenetische Reaktion, die während der Proving-Studie hervorgerufen wurde, erweitert den
Anwendungsbereich des homöopathischen Arzneimittels Cuprum aceticum. Die in dieser Studie erzeugten Symptome haben
einen höheren Wert, wenn sie klinisch verifiziert werden.

醋酸铜的顺势病理实验：多中心、双盲、随机、安慰剂对照试验
背景：虽然铜金属的症状是相当庞大的，它的其他盐有零碎的证明。 因此，采取了铜针的顺势疗法的致病性试验。
目的：探讨顺势疗法对健康人的病理反应。 材料和方法：在顺势疗法研究委员会（CCRH）的三个中心进行了一项
多中心双盲随机安慰剂对照试验。 在进行审前体检后选择的50名相对健康的证明者上进行了证明。 在试验的第一阶
段，所有证明者都给予安慰剂。 在接下来的两个阶段, 在干预组(n=34) 分别以6C和30C的剂量给药；和安慰剂组(n=16)
。在验证实验数据处理单元上，对由此产生的丙酮铜的验证数据进行编辑和分析。结果：34名实际药物试验者中，
只有12人出现症状。30C和200C的药力分别表现出26和20种症状。结论：在验证试验中引发的病理反应扩大了同种顺
势疗法药物醋酸铜的应用范围。临床验证时，此试验产生的症状将更有价值。
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